CLRB
Cellectar Biosciences
$2.42
+$0.01 (+0.41%)Jul 27, 2026
Key metrics
The numbers that frame CLRB today
- Market cap
- $19.34M
- P/E (TTM)
- -0.9
- EV / FCF
- -0.7
- ROIC
- 1,004.8%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $2.20
- 52wk High
- $6.52
Growth
Revenue and earnings trend for CLRB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CLRB
Is Cellectar Biosciences a good buy?
No. Cellectar Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Cellectar Biosciences is selling at a very high price.
What is the market capitalization of CLRB?
Cellectar Biosciences's market capitalization is $19.34M.
What is the P/E ratio for CLRB stock?
Cellectar Biosciences's current P/E ratio is -0.9.
What is the 52-week high for CLRB stock?
The 52-week high for Cellectar Biosciences is $6.52. The current close of $2.42 is 62.9% below that high.
What is the 52-week low for CLRB stock?
The 52-week low for Cellectar Biosciences is $2.20. The current close of $2.42 is 10% above that low.
Does CLRB stock pay dividends?
Cellectar Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CLRB?
Cellectar Biosciences's Debt / Equity ratio is 0.46.